GLS and colorectal carcinoma: Thus, glutamine metabolism or glutaminolysis is equally important for reprogramming CRC cell metabolism by supporting ATP, glutamine metabolism is a promising therapeutic target, and current drug strategies specifically target the inhibition of glutaminase [109].